Research presented by Professor Nigel Bundred at the European Breast Cancer Conference in Amsterdam revealed that they had tested the effectiveness of a pair of drugs known as Herceptin (a.k.a trastuzumab) and Lapatinib.The two drugs are commonly used in breast cancer treatment already, but this is the first time they had been combined together and…

Reblogged this on Health News Disclosure.
LikeLike